Cetraxate

Summary

Cetraxate (INN) is an oral gastrointestinal medication which has a cytoprotective effect.[1][2]

Cetraxate
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 3-[4-[4-(aminomethyl)cyclohexanecarbonyl]oxyphenyl]propanoic acid
CAS Number
  • 34675-84-8
PubChem CID
  • 2680
ChemSpider
  • 2579
UNII
  • 5VPA8CPF0N
KEGG
  • D07663
ChEMBL
  • ChEMBL502896
CompTox Dashboard (EPA)
  • DTXSID2040658 Edit this at Wikidata
Chemical and physical data
FormulaC17H23NO4
Molar mass305.374 g·mol−1
3D model (JSmol)
  • Interactive image
  • O=C(O)CCc2ccc(cc2)OC(=O)C1CCC(CN)CC1

References edit

  1. ^ Kurebayashi Y, Ikeda T, Osada Y (January 1988). "Cytoprotective action of cetraxate against HCl.ethanol-induced gastric lesion in rats". Jpn. J. Pharmacol. 46 (1): 17–25. doi:10.1254/jjp.46.17. PMID 3367546.
  2. ^ Ishimori A, Yamagata S, Taima T (1979). "Effect of p-hydroxyphenyl-propionic ester of tranexamic acid hydrochloride (Cetraxate) on peptic ulcer. Multi-center clinical study". Arzneimittelforschung. 29 (10): 1625–32. PMID 391240.